Immobilized Recombinant Human TRAIL (2 µg/mL) bind Recombinant Human DcR2 in a functional ELISA with a linear range of 15-60 ng/mL. Inhibition of the TRAIL-mediated cytotoxicity using L-929 mouse fibroblast cells treated with TRAIL: ED50 = 1.8-7.2 ng/mL in the presence of 20 ng/mL Recombinant Human TRAIL/TNFSF10.
Purity
>95% (by SDS-PAGE).
Product Form
Lyophilized
Concentration
Reconstitution dependent.
Formulation
Lyophilized from Phosphate Buffered Saline, pH 7.4 (0.22µm filter sterilized).
Endotoxin Level
<0.1 EU/µg of the protein by LAL method.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C up to 1 year from the date of receipt. Reconstituted: Aliquot and store at -20°C for 3 months or 2-8°C for up to 1 week. Avoid freeze/thaw cycles.
Synonyms
CD264, Decoy receptor 2, TNF-related apoptosis-inducing ligand receptor 4, TNFRSF10D, TRAIL receptor 4, TRAIL receptor with a truncated death domain, TRAIL-R4, TRAILR4, TRUNDD, Tumor necrosis factor receptor superfamily member 10D
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Standard Curve - Recombinant Human DcR2 Protein (C-terminal Human Fc and His Tag) (A330520)
ELISA examination of immobilized Recombinant Human TRAIL (2µg/mL) binding Recombinant Human DcR2 Protein (C-terminal Human Fc and His Tag) (A330520): linear range = 15-60 ng/mL.
Recombinant Human DcR2 Protein (C-terminal Human Fc and His Tag) (A330520)
TRAIL-mediated cytotoxicityin L-929 mouse fibroblast cells treated with TRAIL inhibited by Recombinant Human DcR2 Protein (C-terminal Human Fc and His Tag) (A330520): ED50 = 1.8-7.2 ng/mL in the presence of 20 ng/mL Recombinant Human TRAIL/TNFSF10.
Publishing research using Recombinant Human DcR2 Protein (C-terminal Human Fc and His Tag) (A330520)? Please let us know so that we can list the citation on this page.
Proteins predicted to interact with DcR2
Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
